Company news
Teva Pharmaceutical Industries Limited news in 2025
Teva Pharmaceutical Industries Limited's news releases, calls and decks from 2025, newest first.
Teva Announces Launch of $2,000,000,000 (Equivalent) Offering of Senior Notes
May 19, 2025
Teva Announces $2,000,000,000 (Equivalent) Debt Tender Offers For Notes Due 2026-2031
May 19, 2025
Moody's Investor Services Upgrades Teva Amid Continued Success of Pivot to Growth Strategy
May 15, 2025
Teva to Host Innovation & Strategy Day on Thursday, May 29 in New York City
May 7, 2025
Teva Reports Ninth Consecutive Quarter of Growth in Q1 2025 With Key Innovative Medicines Growing ~40%; 2025 Profit Outlook Improved
May 7, 2025
Teva and Alvotech Announce FDA Approval of Interchangeability for SELARSDI™ (ustekinumab-aekn) with Stelara® (ustekinumab)
May 5, 2025
Calls in 2025
- Teva Pharmaceutical Industries (TASE:TEVA) Q3 2025 Earnings Call
Nov 5, 2025
Transcript - Teva Pharmaceutical Industries (TASE:TEVA) Q2 2025 Earnings Call
Jul 30, 2025
Transcript - Teva Pharmaceutical Industries (TASE:TEVA) Q1 2025 Earnings Call
May 7, 2025
Transcript - Teva Pharmaceutical Industries (TASE:TEVA) Q4 2024 Earnings Call
Jan 29, 2025
Transcript
Decks in 2025
- ESG Presentation (December 2025)
Sustainability · 48 slides · December 2025
- Q3 2025 Earnings Presentation
Earnings · 73 slides · Nov 5, 2025
- Technical Presentation (September 2025)
Technical · 27 slides · Sep 22, 2025
- Q2 2025 Earnings Presentation
Earnings · 68 slides · Jul 30, 2025
- Investor Day (May 2025)
Investor day · 99 slides · May 29, 2025
- Q1 2025 Earnings Presentation
Earnings · 60 slides · May 7, 2025
- ECCO 2025 investor call
Conference · 28 slides · Feb 24, 2025
- Q4 2024 Earnings Presentation
Earnings · 62 slides · Jan 29, 2025
- 43rd Annual J.P. Morgan Healthcare Conference (January 2025)
Conference · 32 slides · Jan 13, 2025